The production of protein-based drugs is a cornerstone of modern medicine, offering treatments for a range of conditions from cancer to autoimmune diseases. Central to this process are Chinese hamster ovary (CHO) cells, which are widely used in the biotechnology industry for their ability to
Imagine a world where obesity is not just a physical health challenge but a severe risk factor for life-threatening diseases. The increasing prevalence of obesity in modern society has become a significant concern for public health experts, especially with the stark rise in cancer cases. Delving
Osteosarcoma, a rare and aggressive bone cancer, primarily affects children and young adults during periods of rapid bone growth. Despite its rarity, the impact of osteosarcoma is devastating, often requiring surgery or amputation and posing a high risk of metastasis to the lungs. For decades, the
The field of oncology has witnessed numerous advancements over the years, but the introduction of molecular glue degraders marks a significant leap forward. These innovative small molecules are poised to transform cancer treatment by targeting previously "undruggable" proteins, offering new hope
A phase 1 clinical trial has brought new hope for patients with B-cell lymphoma, a type of blood cancer, through an innovative cell-based immunotherapy. Researchers from Washington University School of Medicine in St. Louis, along with other collaborators, have explored the safety and potential
The transformative impact of rapid in-house next-generation sequencing (NGS) technology on cancer treatment is becoming increasingly evident. This advancement is particularly significant in enabling personalized medicine and improving patient outcomes. With the progress in molecular testing and the
